Tetsuya Shiomi

Kanagawa, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Anxiety, depression, and fear after coronavirus disease 2019 infection and their association with long coronavirus disease symptoms.

Anxiety, depression, and fear after coronavirus disease 2019 infection and their association with long coronavirus disease symptoms.

Journal: Frontiers in psychiatry
Published: July 24, 2025

Idiopathic Interstitial Lung Disease with Positive Anti-Zo and Anti-Ro52/SSA1 Antibodies.

Idiopathic Interstitial Lung Disease with Positive Anti-Zo and Anti-Ro52/SSA1 Antibodies.

Journal: Internal medicine (Tokyo, Japan)
Published: April 06, 2025

Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life.

Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life.

Journal: BMJ open respiratory research
Published: October 05, 2023

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study.

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study.

Journal: Respiratory investigation
Published: March 13, 2023

Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations.

Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations.

Journal: Vaccine: X
Published: October 19, 2022

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

Journal: Nature communications
Published: December 14, 2021

DOCK2 is involved in the host genetics and biology of severe COVID-19.

DOCK2 is involved in the host genetics and biology of severe COVID-19.

Journal: Nature
Published: October 26, 2021

Successful Tepotinib Challenge After Capmatinib-Induced Interstitial Lung Disease in a Patient With Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation: Case Report.

Successful Tepotinib Challenge After Capmatinib-Induced Interstitial Lung Disease in a Patient With Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation: Case Report.

Journal: JTO clinical and research reports
Published: October 20, 2021

Fatal Disseminated Tuberculosis and Concurrent Disseminated Cryptococcosis in a Ruxolitinib-treated Patient with Primary Myelofibrosis: A Case Report and Literature Review.

Fatal Disseminated Tuberculosis and Concurrent Disseminated Cryptococcosis in a Ruxolitinib-treated Patient with Primary Myelofibrosis: A Case Report and Literature Review.

Journal: Internal medicine (Tokyo, Japan)
Published: September 27, 2021

Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report.

Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report.

Journal: Molecular and clinical oncology
Published: August 18, 2021

Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.

Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.

Journal: BMJ open respiratory research
Published: June 10, 2021

A case of lung adenocarcinoma with a novel CD74-ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib.

A case of lung adenocarcinoma with a novel CD74-ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib.

Journal: Thoracic cancer
Published: May 24, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026